Hologic (HOLX) Ratings Affirmed by S&P Following Credit Facility Refinancing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- Wall Street ends down as oil prices, Treasury yields rise
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Plug Power COO resigns to join another company
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
Hologic (HOLX) PT Boosted to $40 at Canaccord Genuity Following Meetings
June 1, 2015 8:43 AM EDTCanaccord Genuity analyst Mark Massaro reiterated a Buy rating and boosted his price target on Hologic (NASDAQ: HOLX) to $40.00 (from $37.00) after hosting investor meetings with Hologic CEO Steve MacMillan and CFO Bob McMahon.
Massaro commented, "Following a really strong quarter, we... More
